Ovarian Cancer Awareness Month Spotlight: Norma Livingston Ovarian Cancer Foundation

Norma was a healthy, active 65-year-old woman who was rarely sick and had always been proactive about her health. She went to her internist complaining of weight gain, abdominal discomfort, and a chronic cough. When the diagnosis was finally made, Norma had stage 4 ovarian cancer. She endured nine hours of surgery, countless rounds of chemotherapy, and experimental drugs. Thirteen months later, she passed away, leaving three wonderful daughters behind.

Norma’s daughter, Lori Livingston, shared, "My mom was my best friend. She was kind to everyone, smart, inclusive, and had a passion for volunteering. She instilled in us these wonderful traits. When she was diagnosed with ovarian cancer, it felt like her options were limited, and we lost her too soon. I've made it my passion to find a cure and help every woman live a longer life." In honor of her mother, Lori founded the Norma Livingston Ovarian Cancer Foundation (NLOCF) in Birmingham, Alabama in 2004.  The mission of the NLOCF is to raise funds for ovarian cancer research and to increase awareness about the risks, symptoms and treatments of this disease. 

blog image

Norma and her daughter Lori Livingston

When asked about the mission of the NLOCF as well as her own experience, board President Kim Evans reflected, “This October marks my 10th year as an ovarian cancer survivor—or I like to use the term NED (No Evidence of Disease). I don’t like that I had ovarian cancer, but I respect what it has taught me. During my journey, the NLOCF was there the entire way. The NLOCF offered me help and hope during my hardest times. The NLOCF gave me the opportunity to help others, to serve, and to help fight this disease as a board member and President. I am grateful, and I look forward to watching this foundation grow and to help others grow through this disease.” 

President Kim Evans with the NCOLF Junior Board

Kim Evans with NCLOF Junior Board

Through the sale of the Alabama Driving out Ovarian Cancer car tag, the NLOCF has raised over $1.8 million to fund research at the University of Alabama at Birmingham’s (UAB) Division of Gynecologic Oncology and other cancer centers in the state.  When asked about the partnership, Dr. Charles Leath, the UAB Division Director of Gynecologic Oncology shared, “This partnership has been critical in not only raising awareness, which happens every time one sees the license plate, but also in funding important research initiatives that may allow us to better understand the 'why' of ovarian cancer.”

Through individual donors, special events, and foundation support, additional funding has been raised to directly support ovarian cancer patients. For instance, in 2019, under the guidance and direction of partners at UAB, the NLOCF implemented the Just a Need Program to provide direct support services to ovarian cancer patients, survivors, and caregivers through medical assistance, financial assistance, and emotional support. This program was started in honor of board member Erica Thomas’s grandmother, Janice Bauer, who died of ovarian cancer. 

September is Ovarian Cancer Awareness Month. The NLOCF wants people to know:

•    Typical gynecologic cancer screenings, such as an annual GYN exam or pap test, do not usually lead to ovarian cancer detection.1

•    It’s important to learn the signs of ovarian cancer. Some are common symptoms many people often experience unrelated to cancer. These include bloating, pelvic or abdominal pain, feeling full quickly when eating, urinary symptoms such as urgency (feeling like you have to go) or frequency (having to go often), and more.2 If you have any of these symptoms, especially persistently, talk with your healthcare provider.

•    Up to 1 in 4 cases of epithelial ovarian cancer, the most common type of ovarian cancer, are due to a hereditary or inherited cause.3 If you have a personal or family history of ovarian cancer, talk to your healthcare provider or a genetic counselor about hereditary cancer testing

Ambry Genetics honors women like Norma and Janice, and we work toward a future where there are better options for ovarian cancer screening, risk reduction, and treatment.  To support the Norma Livingston Ovarian Cancer Foundation, visit https://cureovariancancer.org/ways-to-give/

____

Notes:
1.    American Cancer Society. (n.d.). How to check for ovarian cancer: Ovarian cancer screening. How to Check for Ovarian Cancer | Ovarian Cancer Screening | American Cancer Society. https://www.cancer.org/cancer/types/ovarian-cancer/detection-diagnosis-staging/detection.html
2.    American Cancer Society. (n.d.-b). Signs and symptoms of ovarian cancer: Early signs of ovarian cancer. Early Signs of Ovarian Cancer | American Cancer Society. https://www.cancer.org/cancer/types/ovarian-cancer/detection-diagnosis-staging/signs-and-symptoms.html
3.    Flaum, N., Crosbie, E., Edmondson, R., Smith, M., & Evans, D. (2019). Epithelial ovarian cancer risk: A review of the current Genetic Landscape. Clinical Genetics, 97(1), 54–63. https://doi.org/10.1111/cge.13566
 

Find Answers & Improve Patient Care

Ambry is committed to delivering the most accurate genetic test results possible. Learn more about our products today.

Love this article?

Get stories just like it, delivered right to your inbox.



Author


Co-authors

Meagan Farmer

Meagan Farmer

Meagan received her M.S. in Genetic Counseling from the University of North Carolina at Greensboro and her M.B.A. from the University of Alabama at Birmingham (UAB).  She was a clinical genetic counselor for ten years and directed the UAB Cancer Genetic Counseling Program, where she also worked with genetic counseling students and other medical learners. She worked for My Gene Counsel, a digital health company founded by genetic counselors, for four years as the Genetic Counseling Business Manager and then Genetic Clinical Operations Director.  She joined Ambry Genetics in 2022. Meagan has special interests in hereditary cancer testing, population health, and leveraging technology to scale genetic services. Meagan has been on the board of the Norma Livingston Ovarian Cancer Foundation since 2018.

DISCLAIMER: THIS BLOG DOES NOT PROVIDE MEDICAL ADVICE

The information, including but not limited to, text, graphics, images and other material contained on this blog are for informational purposes only. The purpose of this blog is to promote broad understanding and knowledge of various health topics. It is not intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this blog. Ambry Genetics Corporation does not recommend or endorse any specific tests, physicians, products, procedures, opinions or other information that may be mentioned on this blog. Reliance on any information appearing on this blog is solely at your own risk.